Article Details

PH.AI CEO Hyde: With Big Data, pharma will focus on the measurement of value

Retrieved on: 2018-03-02 04:59:59

Tags for this article:

Click the tags to see associated articles and topics

PH.AI CEO Hyde: With Big Data, pharma will focus on the measurement of value. View article details on hiswai:

Excerpt

<div>Roche's acquisition of <b>Flatiron Health</b> signals the pharmaceutical industry's interest in using real-world data to measure value, said Brigham Hyde, CEO and founder of Precision Health AI, a company that uses artificial intelligence to define cancer datasets for precision oncology. “If I were a ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up